Organon & Co. (NYSE:OGN), a prominent player in the healthcare sector, has been garnering attention from analysts due to its diverse product portfolio and strategic market positioning. The company ...

Organon's Q1 2025 earnings report showed significant declines across key financial metrics, leading to a drastic 30% drop in share price following a >90% dividend cut. The company's revenue ...

Dear Santa: I’m reaching out early this year because things are going downhill fast re: Christmas. My sister hasn’t stopped crying since Donald Trump warned that “maybe the children will ...

Organon currently expects that it will record approximately $6 million of milestone expense in the first quarter of 2025. Organon does not forecast IPR&D (in process research and development) or ...

Organon, a women’s health-focused pharma company based in Jersey City, expects to eliminate 93 jobs as part of an effort to optimize internal operations. In a filing with the state Department of ...

This Women’s Month, Organon, dedicated to advancing women’s health at every stage of life, is raising awareness on the preventability and treatability of heart disease, urging women to take ...

Organon does not currently expect to record any milestone expense in the fourth quarter of 2024. Organon’s fourth quarter and full year 2024 results have not been finalized and are subject to ...

Organon Philippines, a women’s health company, recently unveiled its Her Health Finder, an online tool that aims to empower women to take control of their health by providing quick, easy access ...

Led by Emman Tiglao, Organon Philippines Country Manager, event participants pledged their commitment to empowering themselves and others on making informed decisions and to take control of their ...

Please provide your email address to receive an email when new articles are posted on . Organon is an independent global health care company dedicated to promoting women’s health. Organon will ...